(Story written by J.T. Mitchell)
On Tuesday, Senator Cindy Hyde-Smith introduced legislation which would control the distribution of chemical abortion drugs.
The Support and Value Expectant (SAVE) Moms and Babies Act, if passed, will prevent labeling changes for already-approved abortion drugs, remote distribution, and the Food and Drug Administration (FDA) from approving new chemical abortion drugs.
According to Hyde-Smith, chemical abortion drugs have high complication rates for incomplete abortions, infections, severe bleeding, and even death.
“Making chemical abortion pills more broadly available without proper medical oversight would endanger the lives of women,” Hyde-Smith said. “I am introducing this bill to codify the important FDA policy that protects women from dangers inherent in mail-order or do-it-yourself chemical abortions.”
In addition to restricting the availability of chemical abortion drugs, the measure will retain the FDA-imposed Risk Evaluation and Mitigation Strategies (REMS) and require health care practitioners to report adverse events induced by an abortion drug to the FDA.
Original cosponsors of the SAVE Moms and Babies Act include Senators Roger Wicker (R-Miss.), Tom Cotton (R-Ark.), Kevin Cramer (R-N.D.), Steve Daines (R-Mont.), Jim Inhofe (R-Okla.), Jerry Moran (R-Kan.), Mike Rounds (R-S.D.), Ben Sasse (R-Neb.), and Rick Scott (R-Fla.)
On top of the original cosponsors, groups that support the bill are Susan B. Anthony List, March for Life Action, National Right to Life, Family Research Council, and the United States Conference of Catholic Bishops.
To read a full summary of the bill, click here.
Other Hyde-Smith related stories: